Three months into the new year and the broad U.S. equity indices have made limited progress to the upside. The Nasdaq composite lead by the healthcare/biotech and select semiconductor sectors has risen 3.28%, while the S&P 500 is essentially flat and the DJIA has actually declined six tenths of 1 percent.If you’ve been nimble and picked the right stocks in […]
Stock Market About Ready to Plunge!By: Brad Gudgeon | Sat, Mar 28, 2015SharePrintEmailLast time, I talked about there being one more rally left and then the market would drop big. I see no change in that outlook (after looking over the Gann Cycles from last Monday, I have determined that the next top would be April 2). I also talked […]
Related BRCMOppenheimer: 4 Tech Stocks That Are Technical BuysBroadcom: Expect Softening Performance Metrics In 2015, But Company Is Still Well Positioned In The MarketBroadcom Brings New Devices for Cable Operators in China – Analyst Blog(Zacks)Broadcom Corporation (NASDAQ: BRCM), QUALCOMM, Inc. (NASDAQ: QCOM) and Xilinx, Inc. (NASDAQ: XLNX) were among the leading semiconductor stocks that had surges in their short interest […]
Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors’ Stock Buyback Follows a Worrying Trend:
General Motors’ announcement that it will buy back $5 billion worth of stock raises the question of whether the stock buyback has turned into a shareholder activist shakedown.G.M. did not open its […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
Tweet
Tweet
Biotech’s 5 Year Run On Top – Is It A Bubble?Credit Suisse: Surging Biotech Stocks Have Done Something That no Other Sector Has Done Before – Biotech is in a league of its ownby Julie VerhageWith the Biotech sector (IBB) (XBT) (FBI) (XLV) significantly outperforming other areas of the market, people are continuing to ask if the sector is in […]
Surveying the Fed’s handiwork during last week’s press conference, Janet Yellen noted that all was awesome except that stocks were now slightly “on the high side” of their historical range. You can say that again! In fact, you can say that any one capable of uttering such tommyrot has been totally bamboozled by Wall Street’s sell-side con artists. Yes, the […]
Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
Last summer, Federal Reserve Chair Janet Yellen said valuations in certain corners of the stock market like biotech were getting “substantially stretched,” and traders have gotten a good laugh at her warning ever since as the stocks resumed their winning ways and raced higher. But given the recent battering of the biotech stocks, the caution recommended by the central bank […]
